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Objective: To estimate the lifetime risk of symptomatic hip osteoarthritis (OA).
Design: We analyzed data from the Johnston County Osteoarthritis Project [a longitudinal population-
based study of OA in North Carolina, United States (n¼ 3068)]. The weighted baseline sample comprised
18% blacks and 54% women, and the mean age was 63 years (range¼ 45e93). Symptomatic hip OA was
deﬁned as a KellgreneLawrence (KeL) radiographic score of 2 (anterioreposterior pelvis X-rays) and
pain, aching or stiffness on most days, or groin pain, in the same hip. Lifetime risk, deﬁned as the
proportion who developed symptomatic hip OA in at least one hip by age 85, among people who live to
age 85, was modeled using logistic regression with repeated measures (through generalized estimating
equations).
Results: Lifetime risk of symptomatic hip OA was 25.3% [95% conﬁdence interval (CI)¼ 21.3e29.3]. Life-
time risk was similar by sex, race, highest educational attainment, and hip injury history. We studied
lifetime risk by body mass index (BMI) in three forms: at age 18; at baseline and follow-up; and at age 18,
baseline and follow-up and found no differences in estimates.
Conclusion: The burden of symptomatic hip OA is substantial with one in four people developing this
condition by age 85. The similar race-speciﬁc estimates suggest that racial disparities in total hip
replacements are not attributable to differences in disease occurrence. Despite increasing evidence that
obesity predicts an increased risk of both hip OA and joint replacement, we found no association between
BMI and lifetime risk.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Symptomatic hiposteoarthritis (OA) canbeahighly disabling form
of lower extremity OA that limits basic activities, such as walking
a few blocks or climbing stairs1, and is the most common indication
for total joint replacementof thehip2. In 2007, approximately 252,000Louise B. Murphy, Division of
ontrol and Prevention, 4770
1, USA. Tel: 1-770-488-5102;
r Ltd on behalf of Osteoarthritis Rehip replacementswereperformed in theUnited States at an estimated
total cost of $4 billion3.
Lifetime risk is the probability of developing a condition over
the course of a lifetime. Whereas prevalence and incidence convey
the population burden of a condition, lifetime risk describes indi-
vidual risk. Lifetime risk has been estimated for various chronic
conditions (e.g., symptomatic knee OA4, breast cancer5, coronary
heart disease6, diabetes7). To our knowledge, the lifetime risk of
symptomatic hip OA has not been reported. We present lifetime
risk estimates e deﬁned as the proportion of the population who
live to age 85 that develop symptomatic hip OA by age 85 e for
symptomatic hip OA in Johnston County, North Carolina. We esti-
mated the lifetime risk of symptomatic hip OA overall and stratiﬁedsearch Society International.
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injury, and body mass index (BMI)damong participants of the
Johnston County Osteoarthritis (JoCo OA) Project.
Methods
The study sample were participants (n¼ 3068) in the JoCo OA
Project, a longitudinal study of the onset and progression of hip and
knee OA among semirural residents of Johnston County, NC, USA.
The JoCo OA Project is the largest population-based, longitudinal
study in the United States to monitor the occurrence and natural
history of hip OA among black andwhitemales and females. Project
methods are described elsewhere8e10. The JoCo OA Project cohort
was selected to be representative of the civilian, noninstitutional-
ized, English-speaking black and white population aged 45 years
who were residents of one of six selected townships of Johnston
County for at least 1 year, and who were physically and mentally
capable of completing the study’s protocol.
The study protocol at both baseline (1990e1997) and ﬁrst follow-
up (1999e2003) included an initial home interview, a clinical
examination (including X-rays), and a second home interview
approximately 2 weeks after the clinical examination. X-rays
included supine anteroposterior radiographs of the hip, which were
read for radiographic hip OA using KellgreneLawrence (KeL) grades
by one bone and joint radiologist (JBR)11. The intra-rater and inter-
rater reliabilityof the JBRwere previously determined to behighwith
a weighted kappa of 0.89 (intra-rater) and 0.86 (inter-rater)9. Pelvic
radiographs were not obtained fromwomen of reproductive age (i.e.,
<50 years), therefore thesewomenwere included in only the follow-
up sample of this analysis. Weight and height were physically
measured by staff at the baseline and ﬁrst follow-up.
Study participants completed an interviewer administered
questionnaire that measured sociodemographic and clinical char-
acteristics including age, sex, race, educational attainment, income,
history of hip injury, and the presence of hip symptoms [“On MOST
days do you have pain, aching or stiffness in your left (or right)
hip?”]. In the baseline questionnaire, participants reported their
height and weight at age 18. Because symptoms of hip OA may
manifest in a broader region of the hip12, the trained examiner
queried participants about their pain at numerous sites in the
broader hip region (e.g., left and right groin pain) using a stan-
dardized history and examination protocol.
Multiple strategies were used to minimize cohort attrition
between baseline and follow-up (e.g., annual newsletters, adver-
tisements in local media and medical and community settings,
inquirie throughout the community). Participants’ deaths were
identiﬁed by reviewing local obituaries, North Carolina state and
local death records, and the US National Death Index (NDI) and
through word of mouth. The NDI is the most complete and accurate
source of US mortality data with the sensitivity ranging from 93 to
98% and speciﬁcity of virtually 100%13,14.
Analysis
First, we examined the baseline sociodemographic characteris-
tics, symptoms and OA status. Next, we estimated the lifetime risk
for symptomatic hip OA. Symptomatic hip OA was deﬁned as the
presence of both radiographic KeL grade 2 (at least mild radio-
graphic OA11) in at least one hip and hip symptoms reported in the
radiographically affected joint. To determine whether estimates
varied with symptom deﬁnition, we estimated lifetime risk using
two deﬁnitions: (1) the presence of pain, aching, or stiffness in the
radiographically affected hip or (2) the presence of pain, aching, or
stiffness or groin pain in the radiographically affected hip. The
estimates were similar for the two deﬁnitions (reported in results),and so we used the second, or broader, deﬁnition for the remainder
of the analyses. The analysis was person-based (i.e., unit of analysis
was person rather than hip). Hips with radiographic evidence of
inﬂammatory arthritis (i.e., rheumatoid arthritis) at baseline or
follow-up were excluded, and joints that had undergone replace-
ment were classiﬁed as affected with symptomatic hip OA because
hip OA is the most common indication for hip replacements2.
The overall lifetime risk for symptomatic hip OA was estimated
as a model-predicted prevalence of symptomatic hip OA at age 85
for thosewho survived to at least this age; in thismodel, agewas the
independent variable and symptomatic hip OA was the dependent
variable. We then estimated lifetime risks stratiﬁed by sex, race,
highest educational attainment, BMI, and history of hip injury. BMI,
educational attainment, and history of hip injury were modeled as
time-dependent variables, that is, we analyzed participants’ values
at each time point. BMI was examined in three separate models: (1)
at age 18, (2) at baseline and follow-up, and (3) in a summary of BMI
over the life course (i.e., BMI at age 18, at baseline, and at follow-up).
In models 1 and 3, BMI was examined as a two category vari-
abledunder/normal weight or overweight/obesedbecause there
was insufﬁcient sample size to examine overweight and obese
separately.
When considering how to model BMI, continuous BMI at
baseline and follow-up were compared. Participants’ BMI, on
average, increased by only 1.0 unit at follow-up. A potential inter-
action between age and categorized BMI in association with
symptomatic hip OA was evaluated; it was not statistically signiﬁ-
cant (P¼ 0.114). Because there is no published evidence that
a change of 1.0 BMI unit changes risk of OA onset, BMI (categorized)
was treated as a time-dependent covariate (that is, the BMI of
participants at each observation point was analyzed). We also
modeled lifetime risk with BMI at age 18 as a continuous variable.
We observed a curvilinear relationship resulting from unstable
estimates for the small number of respondents who were over-
weight/obese at age 18 and had a high lifetime risk.
Lifetime risk is the probability of developing a condition over
a lifetime. This lifetime probability is equal to the cumulative inci-
dence of a condition over the cohort’s lifetime. Furthermore, the
cumulative incidence of symptomatic hip OA is equal to lifetime
prevalence because symptomatic hip OA is a persistent, low-
mortality condition. There are at least two strengths to including all
cohort members, regardless of OA status at baseline. First, OA
symptoms may be intermittent or abate (e.g., responsiveness to
treatment of symptoms). By including prevalent and incident cases,
we captured a higher proportion of participants who have ever had
symptomatic OA. Second, the cumulative aspect of the lifetime risk
estimate ensures data from all participants, including those who
may subsequently die or leave the cohort for other reasons (e.g.,
move outside the catchment area), whichmay reduce selection bias.
Estimates were derived from logistic regressionmodels by using
generalized estimating equations (GEE). We used GEE logistic
regression, rather than traditional time-to-event survival analysis
methods used in other studies of lifetime risk, for several reasons.
First, many participants had the condition of interest at baseline,
which would exclude them from a time-to-event analysis. Second,
there was considerable cohort attrition between baseline and
follow-up, typical in cohort studies. Therefore, life table analysis
would result in an overestimation of risk because of the extensive
censoring among those participants who were absent at follow-up.
Finally, while survival analysis methods are indicated when
modeling time-to-event, in studies of onset of slowly evolving
conditions, such as OA, a precise measure of the time-to-event, or
date of OA onset, is unknownwithout frequent follow-up of cohort
members. Therefore, without a date of OA onset, lifetime risks were
derived using GEE logistic regression. GEE logistic regression
Fig. 1. Study sample at baseline and ﬁrst follow-up. *Baseline response rate¼ 3068/
5138¼ 60%; clinic cooperation rate¼ 3068/3690¼83%. yWomen aged <50 years (i.e.,
reproductive age) did not have pelvic radiographs (n¼ 312). yFirst follow-up sample
comprised those who completed clinic examination and household interview (response
rate¼ 1590/2228¼ 83%; clinic cooperation rate¼ 1590/1739¼ 91%). All women had hip
radiographs at ﬁrst follow-up because they were aged 50 years.
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vation time and therefore provides estimates for points along the
KaplaneMeier curve, similar to estimates derived in a more tradi-
tional time-to-event analysis. The sample analyzed comprised
people aged 45e93 years and therefore the predicted probabilities
were interpolated (i.e., based on a set of known data points for
younger and older cohort members) rather than projected from
a sample of younger participants.
We conducted a preliminary analysis to assess whether the
relationship between age and lifetime risk was linear. Continuous
age was modeled as untransformed and transformed [i.e., loga-
rithm (age), square root (age1/2), and the addition of a quadratic
term (ageþ age2)]. Untransformed continuous age was used in the
remaining analyses because its association with lifetime risk
provides a simpler (linear) interpretation, the quadratic age term
was not statistically signiﬁcant at a¼ 0.05, and the P values for the
ln(age) and age1/2 terms were similar in signiﬁcance (P¼ 0.001) to
the untransformed age term.
We estimated the probability of developing symptomatic hip OA
by age 85. Analyses were conducted in SUDAAN15, with adjustment
for three sources of error resulting from the study designdrepeated
measures across study participants, multiple participants per
household, and a two-stage clustered sampling design.
We conducted a sensitivity analysis to determine the potential
bias of cohort attrition on the lifetime risk estimate. First, we con-
ducted backward selection logistic regression [explanatory vari-
ables were age (5 year categories); sex; race; educational
attainment; BMI at age 18; and BMI at baseline (history of hip injury
was not included because of insufﬁcient sample size)] to identify
risk factors (at a¼ 0.10) for onset of symptomatic hip OA between
baseline and follow-up. Age and race were signiﬁcantly associated
with incident disease. Second, we calculated the proportion of the
sample that each combination of the two strata, including missing
values, represented. Steps one and two of these analyses were
limited to participants who did not have symptomatic hip OA at
baseline.
Third, using the proportions estimated in the previous step, we
selected a random sample from each of the ﬁve groups of nonpar-
ticipants at follow-up (i.e., had a household interviewonly, declined
participation, lost to follow-up, moved from study area, physically
or mentally unable to participate). Fourth, we estimated the overall
lifetime risk: Randomly selected personswere recoded as havingOA
at follow-up and remainingmembers of each groupwere recoded as
unaffected. We conducted steps three and four 10 times to deter-
mine the range of the simulated lifetime risk estimates.
Results
The average age of the 2756 eligible participants at baseline was
63 years (range¼ 45e93 years). The baseline sample excluded 321
women who were ineligible for having X-rays at baseline because
they were aged <50 years (Fig. 1). The weighted sample comprised
18% blacks, 53%women, and 55%with an annual income of<$20,000
(Table I). Sixty-ﬁve percent of the participants were married or in
common-law marriages, and 58% had at least a high school educa-
tion. Only 11% of participants reported being overweight or obese at
age 18, but 67% were overweight or obese at baseline. Forty-one
percent reported hip or groin symptoms, and 13% had symptomatic
OA in at least one hip at baseline when symptoms were deﬁned as
either the presence of pain, aching, or stiffness or groin pain.
The overall lifetime risk for symptomatic hip OAwas 24.2% (data
not presented) when the deﬁnition of symptoms was limited to
presence of pain, aching, or stiffness. The lifetime risk increased
minimally to 25.3% when deﬁned as the presence of either pain,
aching, or stiffness or groin pain (Table II and Fig. 2). The overalllifetime risk estimated in the sensitivity analysis (i.e., simulation of
estimate as if there was no loss to follow-up) was 29.4%
(range¼ 29.1e29.9%) (data not presented).
Womenwere 10% more likely than men to develop symptomatic
hip OA [28.6% (95% CI¼ 23.6e33.6) vs 18.5% (95% CI¼ 12.5e24.5)]
(Table II). There were no differences in lifetime risk by race or
education levels. The lifetime risk for participantswho reported a hip
injury in the symptomatic and radiographic affected hip was 50.0%
(95% CI¼ 14.4e85.6) compared with 22.1% (95% CI¼ 18.3e25.8)
among those reporting no injury.
Lifetime risk was similar across levels of BMI at baseline and at
follow-up (Table II and Fig. 2). Similarly, the lifetime risk for
participants reporting being under or normal weight (26.4%) at age
18 was similar to participants who reported being overweight or
obese (21.7%, respectively) (Table II). We examined BMI across three
points (age 18, baseline, and follow-up). There was sufﬁcient
sample size to examine BMI trajectories among only those who
reported being under or normal weight at age 18. We found no
statistically signiﬁcant differences across the estimates.Discussion
The overall lifetime risk for symptomatic hip OA was 25.3%,
suggesting that one in four Johnston County residents who live to
age 85 is at risk of developing symptomatic hip OA. Although it was
not a statistically signiﬁcant difference, the lifetime risk was higher
for women (28.6%) than men (18.5%), which is consistent with
previous prevalence and incidence studies of symptomatic hip OA16.
We found similar lifetime risks for blacks and whites, and the
race-speciﬁc prevalence of symptomatic hip OA in the JoCo Project
cohort also was the same for blacks and whites8. The race-speciﬁc
prevalence of radiographic hip OA has been compared in at least
four other studies. Two African studies found a lower prevalence
among blacks17,18, whereas two US studiesda national, population-
based National Health and Nutrition Examination Survey I
(NHANES I) survey19 and a survey of senior citizen centers in
Table II
Lifetime risk of symptomatic* hip OA in the JoCo OA Project cohort
Stratiﬁed Proportiony (95% CI)
Sex
Men 18.5 (12.5e24.5)
Women 28.6 (23.6e33.6)
Race
Black 23.9 (20.2e27.6)
White 26.0 (21.2e30.7)
Educationz
Less than high school 24.3 (18.8e29.7)
Completed high school 27.6 (23.5e31.8)
More than high school 23.2 (20.9e29.7)
BMI at age 18 years**
Underweight or normal (<25) 24.6 (20.3e28.9)
Overweight or obese (25) 20.6 (7.5e33.6)
BMIz,**
Underweight or normal (<25) 25.5 (18.2e32.7)
Overweight (25 to <30) 23.5 (17.8e29.2)
Obese (30) 31.1 (23.1e39.2)
History of hip injuryzyy
No 22.1 (18.3e25.8)
Yes 50.0 (14.4e85.6)
Overallzz 25.3 (21.3e29.3)
* Symptomatic was deﬁned as either “pain, aching, or stiffness in at least one hip
joint” or “pain in groin” in the radiographically affected hip.
y Weighted to Johnston County population distribution in the 1990 United States
Census.
z Education, BMI, and history of hip injury were time dependent (i.e., participants’
measurements at baseline and follow-up were analyzed).
** BMI at age 18was calculated from self-reported height andweight. Baseline BMI
was calculated from height and weight measurements at baseline clinical
examination.
yy History of hip injury in the symptomatic and radiographically affected joint.
zz Stratiﬁed lifetime risk estimates may not sum to overall lifetime risk estimate
because of missing data for stratiﬁcation variables (Table I).
Table I
Selected sociodemographic and clinical characteristics of JoCo OA Project cohort at
baselinedhip analyses (n¼ 2756*)
Variable Percentagey,z,**
Age (years)
45e59 42
60e74 44
75 14
Women 53
Black 18
Marital status
Married/common-law 65
Widowed 23
Household income <$20,000 per year 55
Education
Less than high school 42
Completed high school 32
More than high school 26
BMI at age 18yy
Under or normal (<25) 89
Overweight or obese (25) 11
BMIyy
Under or normal (<25) 32
Overweight (25e<30) 42
Obese (30) 25
Symptomszz
Pain, aching, or stiffness in at least one hip 37
Pain in groin 16
Pain, aching, or stiffness in at least one
hip or pain in groin
41
Symptomatic OA in at least one hip*** 12
Total joint replacement in at least one hipyyy <1
History of hip injury
In either hip 6
In radiographically affected hip 1
* Excludes 312 women of reproductive age who were ineligible for hip radio-
graphs at baseline but eligible for hip radiographs at ﬁrst follow-up. The charac-
teristics of the entire cohort (n¼ 3068) at baseline are described elsewhere4.
y Weighted to Johnston County population distribution in the 1990 United States
Census.
z Some percentages were rounded and may not equal 100.
** The denominator of percentages does not include participants with the
following missing baseline data: marital status (n¼ 1); income (n¼ 545); education
(n¼ 7); BMI at age 18 (n¼ 130); BMI (n¼ 92); history of hip injury (n¼ 7); pain,
aching, and/or stiffness in at least one hip (n¼ 61); hip replacement status (n¼ 61);
groin pain (n¼ 28); radiographs for both hips (n¼ 49); symptoms and radiographs
for both hips (n¼ 40).
yy BMI at age 18was calculated from self-reported height andweight. Baseline BMI
was calculated from height and weight measurements taken at baseline clinical
examination.
zz Independent of hip radiographic OA status.
*** Symptomatic was deﬁned as either “pain, aching, or stiffness in at least one hip
joint” or “pain in groin” in the radiographically affected hip. This includes people
with total hip replacements in at least one hip.
yyy Observed in radiographs.
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blacks and whites. Hip replacements are a well recognized and
effective procedure for reducing pain and improving physical
function among people with debilitating hip OA. Some studies have
found evidence of greater unmet need for hip replacements among
blacks compared with whites20. Our analysis did not account for
differences in symptom severity, an indication for hip replacement.
However, the similar race-speciﬁc risk estimates suggest an equal
need for hip replacements for blacks and whites.
Lifetime risk also was similar across education levels. Education
was used as an indicator of socioeconomic status because self-reported income data were missing for a high proportion (20%) of
the baseline study sample, which is consistent with many epide-
miologic studies21. At least one previous study has found an asso-
ciation between education and prevalent hip OA22, but education is
not a recognized risk factor for incident disease23.
Although lifetime risk was higher for participants with a self-
reported hip injury [50.0% (95% CI¼ 14.4e85.6)] than those
without [22.1% (95% CI¼ 18.3e25.8)], the difference was not
statistically signiﬁcant. Hip injury and onset of hip OA have been
linked in previous studies19,24. The lack of association in this study
may have resulted from the small number of people who reported
a hip injury in the radiographically affected hip at baseline.
The association between BMI and total hip replacement is
strong25e27, but the evidence for association using other deﬁnitions
of hip OA is equivocal. A meta-analysis of studies examining the
association between BMI and hip OA indicatedmoderate evidence of
a relationship (summary odds ratio¼ 2) between BMI and hip OA
when all studies were considered (i.e., studies including clinical and
radiographic deﬁnitions) but no relationship when limited to studies
examining radiographic disease only28. Four longitudinal studies
have reported that obesity at age 18 predicts a moderate to strongly
increased risk for symptomatic hip OA and hip joint replacements in
later life25,26,29,30. Obesity at age 18 and at the time of hip replace-
ment was independently associated with an increased risk for total
hip replacement among women in the Nurses Cohort Study25.
However, another study reported that obesity in early life was
associated with an increased risk for hip replacement, but weight
gain in the fourth and ﬁfth decades of life did not predict later risk for
hip replacement31. We found similar risks in all BMI analyses which
Fig. 2. Lifetime risk of symptomatic* hip OA in the JoCo OA. *Symptomatic was deﬁned
as either “pain, aching, or stiffness in at least one hip joint” or “pain in groin” in the
radiographically affected hip. yWeighted to Johnston County population distribution in
the 1990 United States Census. zStratiﬁed lifetime risk estimates may not sum to
overall lifetime risk estimate because of missing data for stratiﬁcation variables
(Table 1). **Education, BMI, and history of hip injury were time dependent
(i.e., participants’ measurements at baseline and follow-up were analyzed). yyBMI at
age 18 was calculated from self-reported height and weight. Baseline BMI was calcu-
lated from height and weight measurements at baseline clinical examination. zzHistory
of hip injury in the symptomatic and radiographically affected joint.
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hip OA; to date, too few JoCo study participants have undergone hip
replacement procedures to reliably estimate an association between
BMI and hip replacement. The majority of participants reported
being under or normal weight at age 18. Our analysis of BMI across
three time points found that no differences across varying life course
BMI trajectories; however, because a small proportion of respon-
dents reported being overweight or obese at age 18, there was only
sufﬁcient power to estimate disease risk among respondents who
reported being under or normalweight at age 18. In our study, BMI at
age 18 was self-reported and is likely subject to recall bias32.
Although there was a substantial difference in BMI at age 18 and
baseline, the prevalence of overweight or obesity among all,
including younger, adults has increased substantially in recent
decades33,34; it is plausible that BMI in this cohort was substantially
lower among participants at age 18.
At least seven different deﬁnitions of hip OA have been used
across epidemiologic studies to classify hip OA, including KeL
grades, minimal joint space width (JSW) and Croft’s grade35. KeL
grades are themost commonmeasure35. Two potential limitations of
KeL classiﬁcation are the emphasis on osteophytes35 and potentially
problematic intra- and inter-rater reliability when assessing radio-
logical features relative to a published atlas35,36. Relative to other
measures, KeL grades show lower incidence and similar or lower
prevalence of radiographic hip OA36,37; a strong association between
KeL grades and hip pain among women and people aged 65 years
(comparable or better than JSW)38; moderate to high inter-rater and
intra-rater agreements; similar or higher predictive validity for total
hip replacements compared with JSW and Croft’s grade37,38; and
moderate to strong predictive validity for progression of hip OA,
especially among people with hip pain at baseline37,39.
We provide a model-predicted prevalence of OA by age 85 for
those who achieve this age or older. This can be reasonably inter-
preted as the lifetime risk of OA for people who live to at least 85
years. This differs from a deﬁnition that estimates the risk of disease
for the remaining lifetimes of people who live to varying ages5e7.
However, because age 85 is a reasonable expected lifespan for
individuals in the US, this estimate represents an informative,
helpful, and relevant quantity which would be meaningful to most
individuals, as they see themselves potentially living to that age.
Our results are mortality-adjusted in the sense that we assume that
for the portion of the sample that has died, they would have had OA
in the same proportion as those who lived and are estimated by the
model to have OA by age 85.
Our lifetime risk estimates were likely underestimated for ﬁve
reasons. First, the sensitivity analysis found an estimate of 29.4%. This
slightly higher lifetime risk may indicate an association between
disease status and nonparticipation at ﬁrst follow-up; physical
limitations caused by the onset of symptomatic hip OA between
baseline and follow-up was one reason for nonparticipation at ﬁrst
follow-up. Second, the JoCo OA Project sample comprised men aged
45 years and women aged 50 years (pelvic radiographs were not
obtained for women of reproductive age). The onset of hip OA is very
uncommon among people aged 45 years or younger40,41. Neverthe-
less, there may have been cases of symptomatic hip OA in the
younger Johnston County population that were not captured in this
study.
Third, interviewers determined participants’ history of hip pain
through oral questioning at the household interview. Birrell et al.
reported that schematics are slightly more sensitive than verbal
query in detecting hip pain12. Therefore, a small proportion of
participants in our studywere potentially misclassiﬁed as not having
hip symptoms. As well, we deﬁned symptoms of hip OA as pain in
the hip or groin. However, symptoms of hip OA canmanifest in other
parts of the broad hip region, including the low back. Other sites inthe hip regionwere not included in the analysis because only hip and
groin pain were measured at both baseline and follow-up.
Fourth, OA symptoms may be intermittent42. We derived the
lifetime risk estimate using symptom status at both baseline and
follow-up to increase the likelihood of capturing experience of hip
pain, thus reducing misclassiﬁcation of symptomatic hip OA. Last,
a maximumof 11 years of follow-up datawere available.We believe
that lifetime risk will be higher with increased observation time, as
previous studies of lifetime risk have reported higher probabilities
with increasing observation time6,43,44.
While estimating prevalence and incidence among people aged
85 years can be problematic because of decreased survival (i.e.,
small sample sizes at older ages), the lifetime risk statistic is
a cumulative measure and uses pooled information from across age
groups. Therefore, disease risk at age 85 can be estimated with
increased precision. GEE repeated-measures modeling was used to
reduce selection bias and to increase statistical power, as data for all
cohort members were analyzed, regardless of follow-up status. The
proportion of the sample participating in the ﬁrst follow-up
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completed the X-ray evaluation (Fig. 1)4,10.
We have estimated the lifetime risk of symptomatic hip OA to be
one in four and previously reported the lifetime risk of symptom-
atic knee OA to be nearly one in two. The higher occurrence of
symptomatic knee OA compared with hip OA is consistent with
higher frequency of knee OA observed using other measures of
disease burden (e.g., prevalence and incidence). Various statistical
methods have been used to derive lifetime risk estimates for other
chronic conditions and there is considerable variability in the
characteristics of the samples (e.g., age, race/ethnicity) and
sampling frames (e.g., clinic- vs population-based). We believe that
this substantial heterogeneity precludes comparisons of lifetime
risk estimates across conditions.
We recommend caution in generalizing our results to the US
population. In 1990, the distribution of age and sex in the baseline
Johnston County population was comparable to the US pop-
ulation4,45,46, but the Johnston County population had a higher
proportion of black (18% vs 12%), rural (76% vs 25%), less educated
(35% vs 25% had not completed high school), and lower-income
residents (median income of $25,169 vs $30,056). The differences in
race and education may be unimportant because although Johnston
County had a higher proportion of blacks and people with less
education, we found that lifetime risks were similar by race and
educational attainment. The proportion of overweight or obese
participants aged45 years in theUnited States and JohnstonCounty
were similar [66% in baseline JoCo OA study sample (1990e1997) vs
63.0% in the United States in 1988e1994 NHANES47].
The lifetime risk statistic is considered an accessible statistic
for describing risk to lay audiences. It is familiar to the general
public because it has been used to convey the person-level risk of
other chronic conditions, such as breast cancer48. The JoCo OA
Project is the only longitudinal, population-based study of OA in
the United States that includes blacks and whites of both sexes
who are middle aged and older. The uniqueness of this sample
has enabled us to generate estimates from a sociodemo-
graphically diverse sample. The high lifetime risk for symptom-
atic hip OA observed in our study further illustrates the
substantial public health burden of arthritis across a range of
diverse groups.Disclaimer
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